Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 12 , ISSUE S1 ( July, 2022 ) > List of Articles

Original Article

Comparison of Clinical, Biochemical, and Histopathologic Profiles between NAFLD in Asian-Indians and United States Adults

Shivaram P Singh, Manas K Panigrahi, Anish Patel, Lavanya Viswanathan, Mitali M Rath, Sanjib K Kar, Stephen A Harrison

Keywords : Epidemiology, Ethnicity, Ethnology, NAFLD, Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis

Citation Information : Singh SP, Panigrahi MK, Patel A, Viswanathan L, Rath MM, Kar SK, Harrison SA. Comparison of Clinical, Biochemical, and Histopathologic Profiles between NAFLD in Asian-Indians and United States Adults. Euroasian J Hepatogastroenterol 2022; 12 (S1):S15-S18.

DOI: 10.5005/jp-journals-10018-1362

License: CC BY-NC 4.0

Published Online: 10-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

Background and aims: Nonalcoholic fatty liver disease (NAFLD) is very common in both Asian and Western countries. Geographic variation leads to differences in epidemiological and demographic characters of NAFLD patients. Studies conducted upon different ethnic groups in the United States (US) show a higher prevalence of NAFLD in Hispanics and African-Americans. There is however, a paucity of studies involving Asians. It has been observed that Asian-Indian NAFLD patients have unique characteristics compared to their counterparts in the West. This study is the first attempt at comparing the characteristics of Asian-Indian and US NAFLD patients. Materials and methods: A retrospective analysis of clinical, biochemical, and histological data was performed for 633 Asian-Indian NAFLD patients and 451 US NAFLD patients. Clinical parameters [age, gender, body mass index (BMI), diabetes, hypertension, etc.], biochemical tests (liver function tests, lipid profile, and fasting blood sugar), hepatic ultrasound and hepatic histology were compared between the two cohorts. Results: Eighty-two percent of US NAFLD patients were more than 40 years of age compared to 51.3% of Asian-Indian patients (p <0.01). US (male 56.3%) and Asian-Indian (male 81.7%) (p <0.01) patients differed from each other as regards gender prevalence. Rates of obesity were greater in the US patients compared to Asian-Indians (BMI 32.6 ± 5.3 kg/m2 vs 26.2 ± 3.4 kg/m2). There was a higher prevalence of both diabetes and hypertension (diabetes 42.1% vs 33%, and hypertension 56.8% vs 29.7%, p ≤0.01) in US patients. ALT levels were also significantly higher in US NAFLD patients compared to Asian-Indians (ALT 82.78 ± 71.30 vs 53.66 ± 37, p ≤0.01). A higher proportion of US patients were found to have the more advanced liver disease at the time of diagnosis compared to Asian-Indians (Stage 3 fibrosis 10.42% vs 0%, and Stage 4 fibrosis 2.66% vs 0%, p <0.01). Conclusion: Asian-Indian and US NAFLD patients differ significantly on several parameters. Further studies need to be carried out to understand the mechanistic basis of these differences better.


PDF Share
  1. Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42(1):132–138. DOI: 10.1016/j.jhep.2004.09.012.
  2. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99–S112. DOI: 10.1002/hep.20973.
  3. Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005;42(1):44–52. DOI: 10.1002/hep.20734.
  4. Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011;140(1):124–131. DOI: 10.1053/j.gastro.2010.09.038.
  5. Singh SP, Nayak S, Swain M, et al. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004;25(2):76–79. PMID: 15471321.
  6. Singh SP, Agrawal O, Meher C. Nonalcoholic fatty liver disease (NAFLD) in Orissa. Orissa Physician J 2005;1:8–15.
  7. Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010;51(5):1593–1602. DOI: 10.1002/hep.23567.
  8. Mohan V, Farooq S, Deepa M, et al. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009;84(1):84–91. DOI: 10.1016/j.diabres.2008.11.039.
  9. Amarapurkar D, Kamani P, Patel N, et al. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol 2007;6(3):161–163. PMID: 17786142.
  10. Weston SR, Leyden W, Murphy R, et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005;41(2):372–379. DOI: 10.1002/hep.20554.
  11. Petersen KF, Dufour S, Feng J, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 2006;103(48):18273–18277. DOI: 10.1073/pnas.0608537103.
  12. Madan K, Batra Y, Gupta SD, et al. Non-alcoholic fatty liver disease may not be a severe liver disease at presentation among Asian-Indian. World J Gastroenterol 2006;12(21):3400–3405. DOI: 10.3748/wjg.v12.i21.3400.
  13. Singh SP, Kar SK, Panigrahi MK, et al. Profile of patients with incidentally detected non-alcoholic fatty liver disease (IDNAFLD) in coastal eastern India. Trop Gastroenterol 2013;34(3):144–152. DOI: 10.7869/tg.118.
  14. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34(3):274–285. DOI: 10.1111/j.1365-2036.2011.04724.x.
  15. World Health Organization, Western Pacific region. The Asia-Pacific perspective. Redefining obesity and its treatment. WHO/IASO/IOTF; 2000.
  16. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363(9403):157–163. DOI: 10.1016/S0140-6736(03)15268-3.
  17. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications. Nutrition 2004;20(5):482–491. DOI: 10.1016/j.nut.2004.01.020.
  18. Duseja A, Das A, Das R, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. Dig Dis Sci 2007;52(9):2368–2374. DOI: 10.1007/s10620-006-9136-y.
  19. Misra A, Luthra K, Vikram NK. Dyslipidemia in Asian Indians: determinants and significance. J Assoc Phys India 2004;52:137–142. PMID: 15656049.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.